Castle Biosciences (NASDAQ:CSTL) Shares Down 4.7%

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report)’s share price fell 4.7% during mid-day trading on Tuesday . The stock traded as low as $21.90 and last traded at $22.12. 111,875 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 240,997 shares. The stock had previously closed at […]

Related Keywords

China ,Derekj Maetzold ,Castle Biosciences ,Robertw Baird ,Daniel Bradbury ,Allspring Global Investments Holdings ,China Universal Asset Management Co ,Riverpark Advisors ,Keycorp ,Assetmark Inc ,Wuxi Apptec Co ,Castle Biosciences Inc ,Scotiabank ,Nasdaq ,Get Free Report ,Biosciences Stock Down ,Director Daniel Bradbury ,Park Advisors ,Universal Asset Management ,Global Investments Holdings ,Wuxi Apptec ,Mypath Melanoma ,Castle Biosciences Daily ,